Cure Pharmaceutical Overview

  • Founded
  • 2011
Founded
  • Status
  • Public
  • Employees
  • 19
Employees
  • Stock Symbol
  • CURR
Stock Symbol
  • Investments
  • 4
  • Share Price
  • $1.08
  • (As of Friday Closing)

Cure Pharmaceutical General Information

Description

CURE Pharmaceutical Holding Corp is a biopharmaceutical company focusing on the development and manufacturing of drug formulation and drug delivery technologies in novel dosage forms to improve drug safety, efficacy and patient adherence. Its technology platform includes oral dissolving film (ODF), and encapsulation systems (microCURE) compatible with ODF, chews, oral solutions, topical and transdermal dose forms. It is developing a 50,000IU, once per week, Vitamin D3 ODF for oral administration to be distributed in the United States and the MENA region. Its pharmaceutical drug program includes CUREfilm Blue and CUREfilm Canna.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Stock Exchange
PINX
Primary Office
  • 1620 Beacon Place
  • Oxnard, CA 93033
  • United States
+1 (805) 000-0000

Cure Pharmaceutical Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cure Pharmaceutical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.08 $1.04 $0.96 - $3.06 $57.5M 53.2M 43.7K -$0.32

Cure Pharmaceutical Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 71,883 108,222 43,753 39,564
Revenue 1,080 623 584 180
EBITDA (14,747) (16,740) (7,245) (6,417)
Net Income (15,035) (21,363) (10,401) (8,150)
Total Assets 30,066 32,460 3,396 2,100
Total Debt 2,971 790 6,267 2,402
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cure Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cure Pharmaceutical‘s full profile, request access.

Request a free trial

Cure Pharmaceutical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
CURE Pharmaceutical Holding Corp is a biopharmaceutical company focusing on the development and manufacturing of drug fo
Pharmaceuticals
Oxnard, CA
19 As of 2020
0000
000000000 - 0000

000000 0

d tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercita
0000 00000000
Jerusalem, Israel
00 As of 0000
0000
000000 - 000 0000

000000 0

ercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehe
000000000000000
Durham, NC
0000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cure Pharmaceutical Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oramed Pharmaceuticals Corporation Jerusalem, Israel 00 0000 000000 - 000 0000
000000 000000 Private Equity-Backed Durham, NC 0000000 0000
000000000 00000000 Corporation Saint-Laurent, Canada 00 000.00 000000000 000.00
00000000 Formerly PE-Backed Morristown, NJ 0000 000000&0
000 0000000 Venture Capital-Backed Vero Beach, FL 00 00.00 000000000 00.00
You’re viewing 5 of 30 competitors. Get the full list »

Cure Pharmaceutical Executive Team (9)

Name Title Board Seat Contact Info
Mark Udell Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Michael Redard Chief Financial Officer, Finance
Jessica Rousset Chief Operating Officer, Operations
Vered Gigi Chief Scientific Officer
Jonathan Berlent Chief Business Officer
You’re viewing 5 of 9 executive team members. Get the full list »

Cure Pharmaceutical Board Members (15)

Name Representing Role Since
Anya Goldin JD Self Board Member 000 0000
Gene Salkind MD Self Board Member 000 0000
John Bell Self Board Member 000 0000
Joshua Held Cure Pharmaceutical Board Member 000 0000
Lauren Chung Ph.D Cure Pharmaceutical Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Cure Pharmaceutical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cure Pharmaceutical Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 0000 24-Sep-2020 000000000000000000 0000 Pharmaceuticals 000000 00000000
000000000 00000000 14-May-2019 000000000000000000 000.00 Drug Delivery 000000 00000000
00000000 000000000 11-Jul-2018 000000000 00000 00 Buildings and Property 000000 00000000
CURE Pharmaceutical Holding 07-Nov-2016 Merger/Acquisition Paper/Soft Products
To view Cure Pharmaceutical’s complete investments and acquisitions history, request access »

Cure Pharmaceutical Subsidiaries (1)

Company Name Industry Location Founded
0000 0000 Pharmaceuticals Sherman Oaks, CA 0000
To view Cure Pharmaceutical’s complete subsidiaries history, request access »